Diana Hausman, Chief Medical Officer at Zymeworks Inc. (ZYME), sold 1,048 shares at $34.95 ($37K) on 2021-03-10, disclosed to the SEC on 2021-03-12.
Scheduled sale ($37k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ZYME | SELL | 2020-12-04 | $665K | — | Filing → |
| ZYME | SELL | 2020-12-03 | $2.1M | — | Filing → |
| ZYME | SELL | 2020-09-16 | $1.8M | — | Filing → |